Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy

J Med Virol. 2021 Dec;93(12):6460-6461. doi: 10.1002/jmv.27235. Epub 2021 Aug 2.

Authors

Andreina Baj^{1

2}, Federica Novazzi¹, Francesca D Ferrante¹, Angelo Genoni², Gianluca Cassani¹, Martina Prestia¹, Alberto Colombo¹, Riccardo Capuano¹, Christian Zago¹, Renee Pasciuta¹, Antonio Tamborini¹, Agostino Rossi¹, Elena Tettamanzi³, Giuseppe Catanoso³, Daniele Focosi^{2

4}, Lorenzo Maffioli⁵, Fabrizio Maggi^{1

2}

Affiliations

¹ Laboratory of Microbiology, ASST Sette Laghi, Varese, Italy.
² Department of Medicine and Surgery, University of Insubria, Varese, Italy.
³ ATS Insubria, Varese.
⁴ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
⁵ Chief Medical Officer, ASST Sette Laghi, Varese, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / immunology
Antibodies, Monoclonal, Humanized / pharmacology
COVID-19 / pathology*
Female
Genome, Viral / genetics
Humans
Italy
Middle Aged
Peru
SARS-CoV-2* / drug effects
SARS-CoV-2* / genetics
SARS-CoV-2* / isolation & purification
Severe Acute Respiratory Syndrome / pathology
Severe Acute Respiratory Syndrome / virology
Thyroiditis, Autoimmune / pathology*
World Health Organization

Substances

Antibodies, Monoclonal, Humanized
imdevimab